2nd Quarter - Report
ARENTFOX SCHIFF LLP for ORGANOGENESIS INC.
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Food and Drug Administration policy on chronic wound healing products
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES RAVITZ | — |
| DAN RENBERG | — |
Medicare/Medicaid MMM
Hospital Outpatient Prospective Payment System proposed regulations regarding reimbursement for chronic wound healing product Legislation regarding Medicare reimbursement for chronic wound healing product, including: H.R. 2810 (Medicare Patient Access and Quality Improvement Act of 2013), and S.1871 (SGR Repeal and Medicare Beneficiary Access Act of 2013)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES RAVITZ | — |
| DAN RENBERG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.